- Home
- VRCA vs LRFC Comparison
VRCA vs LRFC Comparison
Compare VRCA & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- LRFC
- Stock Information
- Founded
- VRCA 2013
- LRFC 2013
- Country
- VRCA United States
- LRFC United States
- Employees
- VRCA N/A
- LRFC N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- VRCA Health Care
- LRFC Finance
- Exchange
- VRCA Nasdaq
- LRFC Nasdaq
- Market Cap
- VRCA 43.0M
- LRFC 47.7M
- IPO Year
- VRCA 2018
- LRFC 2013
- Fundamental
- Price
- VRCA $0.42
- LRFC $17.95
- Analyst Decision
- VRCA Hold
- LRFC
- Analyst Count
- VRCA 5
- LRFC 0
- Target Price
- VRCA $6.00
- LRFC N/A
- AVG Volume (30 Days)
- VRCA 243.3K
- LRFC 14.0K
- Earning Date
- VRCA 05-13-2025
- LRFC 05-08-2025
- Dividend Yield
- VRCA N/A
- LRFC 8.00%
- EPS Growth
- VRCA N/A
- LRFC N/A
- EPS
- VRCA N/A
- LRFC N/A
- Revenue
- VRCA $7,566,000.00
- LRFC $20,916,000.00
- Revenue This Year
- VRCA $127.58
- LRFC N/A
- Revenue Next Year
- VRCA $88.06
- LRFC N/A
- P/E Ratio
- VRCA N/A
- LRFC N/A
- Revenue Growth
- VRCA 47.66
- LRFC 3.66
- 52 Week Low
- VRCA $0.38
- LRFC $17.30
- 52 Week High
- VRCA $11.41
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- VRCA 39.53
- LRFC 26.14
- Support Level
- VRCA $0.45
- LRFC $17.68
- Resistance Level
- VRCA $0.48
- LRFC $18.06
- Average True Range (ATR)
- VRCA 0.04
- LRFC 0.36
- MACD
- VRCA -0.00
- LRFC 0.17
- Stochastic Oscillator
- VRCA 22.13
- LRFC 9.47
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.